- Home
- HSBC vs ABT Comparison
HSBC vs ABT Comparison
Compare HSBC & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSBC
- ABT
- Stock Information
- Founded
- HSBC 1865
- ABT 1888
- Country
- HSBC United Kingdom
- ABT United States
- Employees
- HSBC N/A
- ABT N/A
- Industry
- HSBC Savings Institutions
- ABT Medical/Dental Instruments
- Sector
- HSBC Finance
- ABT Health Care
- Exchange
- HSBC Nasdaq
- ABT Nasdaq
- Market Cap
- HSBC 172.6B
- ABT 204.9B
- IPO Year
- HSBC N/A
- ABT N/A
- Fundamental
- Price
- HSBC $48.29
- ABT $114.21
- Analyst Decision
- HSBC Hold
- ABT Buy
- Analyst Count
- HSBC 1
- ABT 15
- Target Price
- HSBC N/A
- ABT $129.80
- AVG Volume (30 Days)
- HSBC 1.0M
- ABT 5.2M
- Earning Date
- HSBC 10-29-2024
- ABT 01-22-2025
- Dividend Yield
- HSBC 4.14%
- ABT 1.93%
- EPS Growth
- HSBC N/A
- ABT 12.04
- EPS
- HSBC 1.20
- ABT 3.29
- Revenue
- HSBC $57,970,000,000.00
- ABT $41,217,000,000.00
- Revenue This Year
- HSBC N/A
- ABT $5.73
- Revenue Next Year
- HSBC N/A
- ABT $7.17
- P/E Ratio
- HSBC $7.48
- ABT $34.72
- Revenue Growth
- HSBC N/A
- ABT 3.15
- 52 Week Low
- HSBC $36.93
- ABT $99.71
- 52 Week High
- HSBC $49.18
- ABT $121.64
- Technical
- Relative Strength Index (RSI)
- HSBC 60.77
- ABT 46.60
- Support Level
- HSBC $47.84
- ABT $111.28
- Resistance Level
- HSBC $49.18
- ABT $114.15
- Average True Range (ATR)
- HSBC 0.49
- ABT 1.77
- MACD
- HSBC -0.03
- ABT -0.28
- Stochastic Oscillator
- HSBC 52.41
- ABT 47.56
About HSBC HSBC Holdings plc.
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and 40 million customers worldwide. It operates in around 60 countries with around 220,000 full-time staff. The United Kingdom and Hong Kong are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.